Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in mice

Cancer Chemotherapy and Pharmacology

Volumn 21, Issue 3, 1988, Pages 237-240

  Pratesi, G ^a   Gianni, L ^a   Manzotti, C ^a   Zunino, F ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; COLON CANCER; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN;

ANIMAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COLONIC NEOPLASMS; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; MICE; SUPPORT, NON-U.S. GOV'T;

EID: 0023932814     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00262777     Document Type: Article

References (28)

1. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-Fluorouracil
2. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-β-D-arabinosylcytosine
3. Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate
4. A phase II study of high dose cis-diamminedichloroplatinum II in non testicular tumors
5. The effect of sulfhydryl compounds on 5-Fluorouracil toxicity and distribution
6. Adjuvant chemotherapy with cis-diamminedichloroplatinum II and 120-hour infusion 5-Fluorouracil in stage III and IV squamous cell carcinoma of the head and neck
7. Significance of the labeling index and labeling distribution as kinetic parameters in colorectal mucosa of cancer patients and DMH treated animals
8. High-Dose Cisplatin in the treatment of Advanced Adenocarcinoma of the Colon and Rectum: A South Eastern Cancer Study Group Trial
9. Combination Chemotherapy of Cisplatin and 5-FU in Advanced Colorectal Carcinoma
10. Cisplatin Plus 5-FU for the Treatment of Adenocarcinoma of the Colon
11. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel
12. Alteration in hepatic and renal level of glutathione and activities of glutathione s-transferases from rats treated with cis-dichlorodiammineplatinum-II
13. Optimal schedule for 5-Fluorouracil chemotherapy
14. The antitumoral activity of 4′-deoxydoxorubicin compared to doxorubicin and 5-Fluorouracil on methylazoxymethanol acetate-induced colon tumors in CF1 mice
15. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin
16. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells
17. Quantitative evaluation of anticancer agent activity in experimental animals
18. Cis-dichlorodiammineplatinum (II): combination chemotherapy and cross-resistance studies with tumors of mice
19. Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine
20. Synergistic antitumor activity of cis-platin (DDP) and 5-Fluorouracil (FUra) in mice bearing leukemia L1210 cells
21. Preclinical drug development: rationale and methods
22. Interval and sequence dependent lethal effects of cis-diamminedichloroplatinum (cis-pt) in combination with other agents
23. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats
24. Antitumor activity of cis-dichlorodiammineplatinum (II)